HEADER HYDROLASE 28-DEC-02 1OA3 TITLE COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED TITLE 2 SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDO-BETA-1-4-GLUCANASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: RESIDUES 17-234; COMPND 5 SYNONYM: ENDOGLUCANASE, CEL12A; COMPND 6 EC: 3.2.1.4; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HYPOCREA SCHWEINITZII; SOURCE 3 ORGANISM_TAXID: 36924; SOURCE 4 EXPRESSION_SYSTEM: ASPERGILLUS NIGER; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 5061 KEYWDS HYDROLASE, CELLULASE, CELLULOSE DEGRADATION, ENDOGLUCANASE, GLYCOSYL KEYWDS 2 HYDROLASE, GH FAMILY 12, HYPOCREA SCHWEINITZII CEL12A EXPDTA X-RAY DIFFRACTION AUTHOR M.SANDGREN,P.J.GUALFETTI,A.SHAW,L.S.GROSS,M.SALDAJENO,A.G.DAY, AUTHOR 2 T.A.JONES,C.MITCHINSON REVDAT 5 13-DEC-23 1OA3 1 HETSYN REVDAT 4 29-JUL-20 1OA3 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 11-MAR-20 1OA3 1 SEQRES LINK REVDAT 2 24-FEB-09 1OA3 1 VERSN REVDAT 1 27-MAR-03 1OA3 0 JRNL AUTH M.SANDGREN,P.J.GUALFETTI,A.SHAW,L.S.GROSS,M.SALDAJENO, JRNL AUTH 2 A.G.DAY,T.A.JONES,C.MITCHINSON JRNL TITL COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED JRNL TITL 2 SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY JRNL REF PROTEIN SCI. V. 12 848 2003 JRNL REFN ISSN 0961-8368 JRNL PMID 12649442 JRNL DOI 10.1110/PS.0237703 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 83042 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2573 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6648 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 596 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.06000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : -0.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.34000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.225 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.157 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.089 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.627 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1OA3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-DEC-02. REMARK 100 THE DEPOSITION ID IS D_1290011924. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 85680 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09700 REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.12000 REMARK 200 FOR SHELL : 5.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1H8V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.77350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG SER C 169 OG SER D 169 2546 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 38 CB - CG - CD1 ANGL. DEV. = 13.6 DEGREES REMARK 500 ASP A 126 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 181 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP C 91 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP D 91 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 13 -124.46 48.78 REMARK 500 ASN B 13 -125.48 51.56 REMARK 500 ILE B 127 165.50 -40.31 REMARK 500 PHE B 202 -64.55 -109.35 REMARK 500 PHE C 202 -65.07 -109.41 REMARK 500 ASN D 13 47.93 39.81 REMARK 500 PHE D 202 -65.74 -107.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C2024 DISTANCE = 5.85 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H8V RELATED DB: PDB REMARK 900 THE X-RAY CRYSTAL STRUCTURE OF THE TRICHODERMA REESEI FAMILY 12 REMARK 900 ENDOGLUCANASE 3, CEL12A, AT 1.9 E RESOLUTION REMARK 900 RELATED ID: 1OA2 RELATED DB: PDB REMARK 900 COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED REMARK 900 SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY REMARK 900 RELATED ID: 1OA4 RELATED DB: PDB REMARK 900 COMPARISON OF FAMILY 12 GLYCOSIDE HYDROLASES AND RECRUITED REMARK 900 SUBSTITUTIONS IMPORTANT FOR THERMAL STABILITY DBREF 1OA3 A 1 218 UNP Q8NJY6 Q8NJY6 17 234 DBREF 1OA3 B 1 218 UNP Q8NJY6 Q8NJY6 17 234 DBREF 1OA3 C 1 218 UNP Q8NJY6 Q8NJY6 17 234 DBREF 1OA3 D 1 218 UNP Q8NJY6 Q8NJY6 17 234 SEQADV 1OA3 PCA A 1 UNP Q8NJY6 GLN 17 MODIFIED RESIDUE SEQADV 1OA3 PCA B 1 UNP Q8NJY6 GLN 17 MODIFIED RESIDUE SEQADV 1OA3 PCA C 1 UNP Q8NJY6 GLN 17 MODIFIED RESIDUE SEQADV 1OA3 PCA D 1 UNP Q8NJY6 GLN 17 MODIFIED RESIDUE SEQRES 1 A 218 PCA THR SER CYS ASP GLN TYR ALA THR PHE SER GLY ASN SEQRES 2 A 218 GLY TYR ILE VAL SER ASN ASN LEU TRP GLY ALA SER ALA SEQRES 3 A 218 GLY SER GLY PHE GLY CYS VAL THR SER VAL SER LEU ASN SEQRES 4 A 218 GLY ALA ALA SER TRP HIS ALA ASP TRP GLN TRP SER GLY SEQRES 5 A 218 GLY GLN ASN ASN VAL LYS SER TYR GLN ASN VAL GLN ILE SEQRES 6 A 218 ASN ILE PRO GLN LYS ARG THR VAL ASN SER ILE GLY SER SEQRES 7 A 218 MET PRO THR THR ALA SER TRP SER TYR SER GLY SER ASP SEQRES 8 A 218 ILE ARG ALA ASN VAL ALA TYR ASP LEU PHE THR ALA ALA SEQRES 9 A 218 ASN PRO ASN HIS VAL THR TYR SER GLY ASP TYR GLU LEU SEQRES 10 A 218 MET ILE TRP LEU GLY LYS TYR GLY ASP ILE GLY PRO ILE SEQRES 11 A 218 GLY SER SER GLN GLY THR VAL ASN VAL GLY GLY GLN THR SEQRES 12 A 218 TRP THR LEU TYR TYR GLY TYR ASN GLY ALA MET GLN VAL SEQRES 13 A 218 TYR SER PHE VAL ALA GLN SER ASN THR THR SER TYR SER SEQRES 14 A 218 GLY ASP VAL LYS ASN PHE PHE ASN TYR LEU ARG ASP ASN SEQRES 15 A 218 LYS GLY TYR ASN ALA GLY GLY GLN TYR VAL LEU SER TYR SEQRES 16 A 218 GLN PHE GLY THR GLU PRO PHE THR GLY SER GLY THR LEU SEQRES 17 A 218 ASN VAL ALA SER TRP THR ALA SER ILE ASN SEQRES 1 B 218 PCA THR SER CYS ASP GLN TYR ALA THR PHE SER GLY ASN SEQRES 2 B 218 GLY TYR ILE VAL SER ASN ASN LEU TRP GLY ALA SER ALA SEQRES 3 B 218 GLY SER GLY PHE GLY CYS VAL THR SER VAL SER LEU ASN SEQRES 4 B 218 GLY ALA ALA SER TRP HIS ALA ASP TRP GLN TRP SER GLY SEQRES 5 B 218 GLY GLN ASN ASN VAL LYS SER TYR GLN ASN VAL GLN ILE SEQRES 6 B 218 ASN ILE PRO GLN LYS ARG THR VAL ASN SER ILE GLY SER SEQRES 7 B 218 MET PRO THR THR ALA SER TRP SER TYR SER GLY SER ASP SEQRES 8 B 218 ILE ARG ALA ASN VAL ALA TYR ASP LEU PHE THR ALA ALA SEQRES 9 B 218 ASN PRO ASN HIS VAL THR TYR SER GLY ASP TYR GLU LEU SEQRES 10 B 218 MET ILE TRP LEU GLY LYS TYR GLY ASP ILE GLY PRO ILE SEQRES 11 B 218 GLY SER SER GLN GLY THR VAL ASN VAL GLY GLY GLN THR SEQRES 12 B 218 TRP THR LEU TYR TYR GLY TYR ASN GLY ALA MET GLN VAL SEQRES 13 B 218 TYR SER PHE VAL ALA GLN SER ASN THR THR SER TYR SER SEQRES 14 B 218 GLY ASP VAL LYS ASN PHE PHE ASN TYR LEU ARG ASP ASN SEQRES 15 B 218 LYS GLY TYR ASN ALA GLY GLY GLN TYR VAL LEU SER TYR SEQRES 16 B 218 GLN PHE GLY THR GLU PRO PHE THR GLY SER GLY THR LEU SEQRES 17 B 218 ASN VAL ALA SER TRP THR ALA SER ILE ASN SEQRES 1 C 218 PCA THR SER CYS ASP GLN TYR ALA THR PHE SER GLY ASN SEQRES 2 C 218 GLY TYR ILE VAL SER ASN ASN LEU TRP GLY ALA SER ALA SEQRES 3 C 218 GLY SER GLY PHE GLY CYS VAL THR SER VAL SER LEU ASN SEQRES 4 C 218 GLY ALA ALA SER TRP HIS ALA ASP TRP GLN TRP SER GLY SEQRES 5 C 218 GLY GLN ASN ASN VAL LYS SER TYR GLN ASN VAL GLN ILE SEQRES 6 C 218 ASN ILE PRO GLN LYS ARG THR VAL ASN SER ILE GLY SER SEQRES 7 C 218 MET PRO THR THR ALA SER TRP SER TYR SER GLY SER ASP SEQRES 8 C 218 ILE ARG ALA ASN VAL ALA TYR ASP LEU PHE THR ALA ALA SEQRES 9 C 218 ASN PRO ASN HIS VAL THR TYR SER GLY ASP TYR GLU LEU SEQRES 10 C 218 MET ILE TRP LEU GLY LYS TYR GLY ASP ILE GLY PRO ILE SEQRES 11 C 218 GLY SER SER GLN GLY THR VAL ASN VAL GLY GLY GLN THR SEQRES 12 C 218 TRP THR LEU TYR TYR GLY TYR ASN GLY ALA MET GLN VAL SEQRES 13 C 218 TYR SER PHE VAL ALA GLN SER ASN THR THR SER TYR SER SEQRES 14 C 218 GLY ASP VAL LYS ASN PHE PHE ASN TYR LEU ARG ASP ASN SEQRES 15 C 218 LYS GLY TYR ASN ALA GLY GLY GLN TYR VAL LEU SER TYR SEQRES 16 C 218 GLN PHE GLY THR GLU PRO PHE THR GLY SER GLY THR LEU SEQRES 17 C 218 ASN VAL ALA SER TRP THR ALA SER ILE ASN SEQRES 1 D 218 PCA THR SER CYS ASP GLN TYR ALA THR PHE SER GLY ASN SEQRES 2 D 218 GLY TYR ILE VAL SER ASN ASN LEU TRP GLY ALA SER ALA SEQRES 3 D 218 GLY SER GLY PHE GLY CYS VAL THR SER VAL SER LEU ASN SEQRES 4 D 218 GLY ALA ALA SER TRP HIS ALA ASP TRP GLN TRP SER GLY SEQRES 5 D 218 GLY GLN ASN ASN VAL LYS SER TYR GLN ASN VAL GLN ILE SEQRES 6 D 218 ASN ILE PRO GLN LYS ARG THR VAL ASN SER ILE GLY SER SEQRES 7 D 218 MET PRO THR THR ALA SER TRP SER TYR SER GLY SER ASP SEQRES 8 D 218 ILE ARG ALA ASN VAL ALA TYR ASP LEU PHE THR ALA ALA SEQRES 9 D 218 ASN PRO ASN HIS VAL THR TYR SER GLY ASP TYR GLU LEU SEQRES 10 D 218 MET ILE TRP LEU GLY LYS TYR GLY ASP ILE GLY PRO ILE SEQRES 11 D 218 GLY SER SER GLN GLY THR VAL ASN VAL GLY GLY GLN THR SEQRES 12 D 218 TRP THR LEU TYR TYR GLY TYR ASN GLY ALA MET GLN VAL SEQRES 13 D 218 TYR SER PHE VAL ALA GLN SER ASN THR THR SER TYR SER SEQRES 14 D 218 GLY ASP VAL LYS ASN PHE PHE ASN TYR LEU ARG ASP ASN SEQRES 15 D 218 LYS GLY TYR ASN ALA GLY GLY GLN TYR VAL LEU SER TYR SEQRES 16 D 218 GLN PHE GLY THR GLU PRO PHE THR GLY SER GLY THR LEU SEQRES 17 D 218 ASN VAL ALA SER TRP THR ALA SER ILE ASN MODRES 1OA3 ASN A 164 ASN GLYCOSYLATION SITE MODRES 1OA3 ASN B 164 ASN GLYCOSYLATION SITE MODRES 1OA3 ASN C 164 ASN GLYCOSYLATION SITE MODRES 1OA3 ASN D 164 ASN GLYCOSYLATION SITE MODRES 1OA3 PCA A 1 GLU PYROGLUTAMIC ACID MODRES 1OA3 PCA B 1 GLU PYROGLUTAMIC ACID MODRES 1OA3 PCA C 1 GLU PYROGLUTAMIC ACID MODRES 1OA3 PCA D 1 GLU PYROGLUTAMIC ACID HET PCA A 1 8 HET PCA B 1 8 HET PCA C 1 8 HET PCA D 1 8 HET NAG A1220 14 HET NAG B1220 14 HET NAG C1220 14 HET NAG D1220 14 HETNAM PCA PYROGLUTAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 PCA 4(C5 H7 N O3) FORMUL 5 NAG 4(C8 H15 N O6) FORMUL 9 HOH *596(H2 O) HELIX 1 1 GLY A 23 GLY A 27 5 5 HELIX 2 2 VAL A 73 ILE A 76 5 4 HELIX 3 3 VAL A 172 LYS A 183 1 12 HELIX 4 4 GLY B 23 GLY B 27 5 5 HELIX 5 5 VAL B 73 ILE B 76 5 4 HELIX 6 6 VAL B 172 LYS B 183 1 12 HELIX 7 7 ASN B 186 GLN B 190 5 5 HELIX 8 8 GLY C 23 ALA C 26 5 4 HELIX 9 9 VAL C 172 LYS C 183 1 12 HELIX 10 10 GLY D 23 GLY D 27 5 5 HELIX 11 11 VAL D 172 LYS D 183 1 12 SHEET 1 BA 6 ALA B 42 SER B 51 0 SHEET 2 BA 6 TYR A 15 SER A 18 0 SHEET 3 BA 6 GLN A 61 ILE A 65 -1 O ASN A 62 N SER A 18 SHEET 4 BA 6 GLN A 196 THR A 199 1 O PHE A 197 N VAL A 63 SHEET 5 BA 6 PRO A 80 ALA A 103 -1 O ALA A 97 N GLY A 198 SHEET 6 BA 6 SER A 167 ASP A 171 -1 O TYR A 168 N ALA A 83 SHEET 1 AA 8 THR A 9 GLY A 12 0 SHEET 2 AA 8 TYR A 15 SER A 18 1 O TYR A 15 N GLY A 12 SHEET 3 AA 8 GLN A 61 ILE A 65 -1 O ASN A 62 N SER A 18 SHEET 4 AA 8 GLN A 196 THR A 199 1 O PHE A 197 N VAL A 63 SHEET 5 AA 8 PRO A 80 ALA A 103 -1 O ALA A 97 N GLY A 198 SHEET 6 AA 8 PRO A 201 ALA A 215 -1 N PHE A 202 O ARG A 93 SHEET 7 AA 8 ALA A 42 SER A 51 -1 O ALA A 42 N TRP A 213 SHEET 8 AA 8 SER A 28 SER A 37 -1 O SER A 28 N SER A 51 SHEET 1 CA 6 SER C 28 SER C 37 0 SHEET 2 CA 6 TYR B 15 SER B 18 0 SHEET 3 CA 6 GLN B 61 ILE B 65 -1 O ASN B 62 N SER B 18 SHEET 4 CA 6 GLN B 196 THR B 199 1 O PHE B 197 N VAL B 63 SHEET 5 CA 6 PRO B 80 ALA B 103 -1 O ALA B 97 N GLY B 198 SHEET 6 CA 6 SER B 167 ASP B 171 -1 O TYR B 168 N ALA B 83 SHEET 1 BB 8 THR B 9 GLY B 12 0 SHEET 2 BB 8 TYR B 15 SER B 18 1 O TYR B 15 N GLY B 12 SHEET 3 BB 8 GLN B 61 ILE B 65 -1 O ASN B 62 N SER B 18 SHEET 4 BB 8 GLN B 196 THR B 199 1 O PHE B 197 N VAL B 63 SHEET 5 BB 8 PRO B 80 ALA B 103 -1 O ALA B 97 N GLY B 198 SHEET 6 BB 8 PRO B 201 ALA B 215 -1 N PHE B 202 O ARG B 93 SHEET 7 BB 8 ALA B 42 SER B 51 -1 O ALA B 42 N TRP B 213 SHEET 8 BB 8 SER B 28 SER B 37 -1 O SER B 28 N SER B 51 SHEET 1 BC 6 ALA B 42 SER B 51 0 SHEET 2 BC 6 TYR D 15 SER D 18 0 SHEET 3 BC 6 GLN D 61 ILE D 65 -1 O ASN D 62 N SER D 18 SHEET 4 BC 6 GLN D 196 THR D 199 1 O PHE D 197 N VAL D 63 SHEET 5 BC 6 PRO D 80 ALA D 103 -1 O ALA D 97 N GLY D 198 SHEET 6 BC 6 SER D 167 ASP D 171 -1 O TYR D 168 N ALA D 83 SHEET 1 DA 8 THR D 9 GLY D 12 0 SHEET 2 DA 8 TYR D 15 SER D 18 1 O TYR D 15 N GLY D 12 SHEET 3 DA 8 GLN D 61 ILE D 65 -1 O ASN D 62 N SER D 18 SHEET 4 DA 8 GLN D 196 THR D 199 1 O PHE D 197 N VAL D 63 SHEET 5 DA 8 PRO D 80 ALA D 103 -1 O ALA D 97 N GLY D 198 SHEET 6 DA 8 PRO D 201 ALA D 215 -1 N PHE D 202 O ARG D 93 SHEET 7 DA 8 ALA D 42 SER D 51 -1 O ALA D 42 N TRP D 213 SHEET 8 DA 8 SER D 28 SER D 37 -1 O SER D 28 N SER D 51 SSBOND 1 CYS A 4 CYS A 32 1555 1555 2.04 SSBOND 2 CYS B 4 CYS B 32 1555 1555 2.05 SSBOND 3 CYS C 4 CYS C 32 1555 1555 2.05 SSBOND 4 CYS D 4 CYS D 32 1555 1555 2.05 LINK C PCA A 1 N THR A 2 1555 1555 1.33 LINK ND2 ASN A 164 C1 NAG A1220 1555 1555 1.43 LINK C PCA B 1 N THR B 2 1555 1555 1.34 LINK ND2 ASN B 164 C1 NAG B1220 1555 1555 1.44 LINK C PCA C 1 N THR C 2 1555 1555 1.33 LINK ND2 ASN C 164 C1 NAG C1220 1555 1555 1.46 LINK C PCA D 1 N THR D 2 1555 1555 1.33 LINK ND2 ASN D 164 C1 NAG D1220 1555 1555 1.44 CRYST1 62.490 77.547 83.410 90.00 98.46 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016002 0.000000 0.002380 0.00000 SCALE2 0.000000 0.012895 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012121 0.00000 HETATM 1 N PCA A 1 25.257 12.399 43.430 1.00 14.81 N HETATM 2 CA PCA A 1 25.136 13.857 43.207 1.00 14.35 C HETATM 3 CB PCA A 1 26.522 14.498 43.253 1.00 14.29 C HETATM 4 CG PCA A 1 27.391 13.508 43.988 1.00 15.09 C HETATM 5 CD PCA A 1 26.618 12.222 43.875 1.00 15.39 C HETATM 6 OE PCA A 1 27.082 11.107 44.132 1.00 17.65 O HETATM 7 C PCA A 1 24.526 14.075 41.847 1.00 13.70 C HETATM 8 O PCA A 1 24.310 13.110 41.113 1.00 13.41 O